Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by indaknownewfieon Apr 21, 2020 9:50pm
58 Views
Post# 30937137

RE:RE:RE:Ppl go back

RE:RE:RE:Ppl go back
Kingofstockst wrote: It's just things don't add up the time frames the food study that was supposed to be done by now, phase 2 no update like what are they hiding no more confidence in this team which is very unfortunate


I get the loss of confidence because the huge thing that stands out is there needs to be better communication between company and its shareholders but they do have the Patents and they do have the Orphan Drug Designations and they do have stellar Phase 2 results because they use them to gain the patents. But whoever is saying they are lying a out that are misleading people. Did anyone ever expect oil to trade below zero! Nope but it happened yesterday for the first time in the history of the stock market. Would i like higher stock price...yeah and so would a lot of the other longs. I could be wrong and lose my money too but I believe in the science. Not a pumper still working my day job....unfortunately. 
<< Previous
Bullboard Posts
Next >>